UK markets closed
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • FTSE 250

    17,972.69
    -359.01 (-1.96%)
     
  • AIM

    833.59
    -13.83 (-1.63%)
     
  • GBP/EUR

    1.1171
    -0.0269 (-2.35%)
     
  • GBP/USD

    1.0820
    -0.0434 (-3.86%)
     
  • BTC-GBP

    17,386.17
    -237.45 (-1.35%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • DOW

    29,590.41
    -486.29 (-1.62%)
     
  • CRUDE OIL

    79.43
    +0.69 (+0.88%)
     
  • GOLD FUTURES

    1,651.70
    -3.90 (-0.24%)
     
  • NIKKEI 225

    27,153.83
    -159.27 (-0.58%)
     
  • HANG SENG

    17,933.27
    -214.63 (-1.18%)
     
  • DAX

    12,284.19
    -247.41 (-1.97%)
     
  • CAC 40

    5,783.41
    -135.09 (-2.28%)
     

Ultimovacs ASA: New share capital registered

·1-min read
Ultimovacs ASA
Ultimovacs ASA

Oslo, 9 September 2022, Ultimovacs ASA (the "Company") refers to the announcement published on 5 September 2022 regarding the issuance of new shares in connection with the Company's employee incentive program.

The share capital increase related to the share issue of 44,000 new shares has been registered in the Norwegian Register of Business Enterprises, and the Company's new share capital is NOK 3,426,576.10, divided into 34,265,761 shares, each with a par value of NOK 0.10.

For further information, please contact:

Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96 355

Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
        
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632